Special Issue "Ion Channels as Therapeutic Targets for Pain"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (30 April 2010) | Viewed by 35553
Special Issue Editor
Interests: capsaicin receptor; gene; genomics; Nerve Growth Factor (NGF); nociceptor; pain; promoter; splice variant; transcription factor-Sp1; TRPV1; VR1
Special Issue Information
Dear Colleagues,
Pain still remains an immense clinical challenge. Our ability to effectively treat acute and especially chronic painful conditions often causes unwanted side-effects that degrade the quality of life. The last decade has seen an explosive growth in our understanding of how the sensation of pain is initiated at the peripheral terminals of primary afferent neurons – nociceptors. These specialized nerve terminals express a diverse array of ion channel - receptors that transduce noxious chemical, thermal and mechanical stimuli. Together, these ion channels serve to detect impending and ongoing tissue damage arising from pathophysiologic states such as inflammation and nerve injury. This section will focus on the therapeutic potential of targeting specific ion channels expressed in nociceptors to more effectively treat painful conditions.
Prof. Dr. Mark A. Schumacher
Guest Editor
Keywords
- TRP channels
- capsaicin receptor
- TRPV1
- TRPA1
- TRPV4
- P2X
- purinergic receptor
- calcium channel
- ASIC
- acid sensing channel
- sodium channel
- NaV 1.8
- NaV 1.9
- TTX-R sodium channel
- potassium channel – two pore
- pain
- primary afferent nociceptor
- analgesia
- nociception